Latest filing published 25 Jun 2026 for MapLight Therapeutics, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +118.3%Entry US$10.05 · Close at T+365 US$21.94
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Martin Babler: trading record in brief
This profile gathers the share dealings of Martin Babler across 4 companies, led by Principia Biopharma Inc., Alumis Inc. and MapLight Therapeutics, Inc. Between 17 December 2015 and 23 June 2026, the trades on record add up to 31 filings.
On the open market, the record shows 1 purchase worth €93k and 14 sales worth €3.1M. Taken together, the sales exceed the purchases by €3.0M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants and 1 option exercise.
The record was last updated on 25 June 2026 with a share grant in MapLight Therapeutics, Inc. The last insider purchase was made public on 3 April 2025, 585 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Martin Babler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,864 sharesVoting Common StockSEC:0001435618-26-000011:0
- 15,650 shares@ US$6.4366100.0% of flowCommon StockSEC:0001415889-25-010049:0Canonical exit: 30 Jun 2025 (T+90)
- 90,804 sharesCommon StockSEC:0001415889-24-018589:1
- 90,804 sharesClass A Common StockSEC:0001415889-24-018589:0
- 1,023 shares@ US$100.001.3% of flowCommon StockSEC:0001209191-20-052222:0
- 39,179 shares@ US$100.0049.9% of flowCommon StockSEC:0001209191-20-052222:1
- 18,355 shares@ US$100.0023.4% of flowCommon StockSEC:0001209191-20-052222:2
- 15,000 shares@ US$3.000.5% of flowCommon StockSEC:0001209191-20-039026:0
- 515 shares@ US$60.320.3% of flowCommon StockSEC:0001209191-20-039026:1
- 11,983 shares@ US$61.828.1% of flowCommon StockSEC:0001209191-20-039026:2
- 2,502 shares@ US$62.381.7% of flowCommon StockSEC:0001209191-20-039026:3
- 2,085 shares@ US$62.451.4% of flowCommon StockSEC:0001209191-20-016684:2
- 7,183 shares@ US$63.245.0% of flowCommon StockSEC:0001209191-20-016684:3
- 5,432 shares@ US$64.103.8% of flowCommon StockSEC:0001209191-20-016684:4
- 300 shares@ US$64.830.2% of flowCommon StockSEC:0001209191-20-016684:5
- 1,159 shares0Common StockSEC:0001209191-20-016684:0
- 1,159 shares0Common StockSEC:0001209191-20-016684:1
- 5,840 shares@ US$51.803.3% of flowCommon StockSEC:0001209191-19-061423:0
- 11,485 shares@ US$52.866.7% of flowCommon StockSEC:0001209191-19-061423:1
- 6,661 shares@ US$53.944.0% of flowCommon StockSEC:0001209191-19-061423:2
- 1,014 shares@ US$54.360.6% of flowCommon StockSEC:0001209191-19-061423:3
- 1,000 shares@ US$52.770.6% of flowCommon StockSEC:0001209191-19-061423:4
- 2,205 shares@ US$53.691.3% of flowCommon StockSEC:0001209191-19-061423:5
- 1,295 shares@ US$54.280.8% of flowCommon StockSEC:0001209191-19-061423:6
- 988 sharesCommon StockSEC:0001209191-18-051828:0
25 of 30 declarations
